Rampart Bioscience

La Jolla, United States

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

$85.0M raised

Oct 2023

Series A

Biopharma Biotechnology Medical Therapeutics

Top Investors

OrbiMedRA Capital ManagementHealthCapForbion Capital Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rampart Bioscience

How much funding has Rampart Bioscience raised?

Rampart Bioscience has raised $85.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are Rampart Bioscience's investors?

Rampart Bioscience's investors include OrbiMed, RA Capital Management, HealthCap, Forbion Capital Partners.

Where is Rampart Bioscience headquartered?

Rampart Bioscience is headquartered in La Jolla, United States.

What does Rampart Bioscience do?

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

What stage is Rampart Bioscience at?

Rampart Bioscience is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2023.

MLA

"Rampart Bioscience — Funding & Investors." VCBacked, October 24, 2023, https://www.vcbacked.co/company/rampart-bioscience. Accessed June 4, 2026.

APA

VCBacked. (2023). Rampart Bioscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/rampart-bioscience

Wikipedia (cite web)

{{cite web |title=Rampart Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/rampart-bioscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2023.

Similar Companies in Biopharma